International Urology and Nephrology

, Volume 11, Issue 3, pp 223–228 | Cite as

Serum and ultradiafiltrate middle molecules in hemodialysed patients

  • P. Božek
  • J. Erben
  • J. Zahradnik
  • R. Dzúrik
Article

Abstract

The gel filtration technique was used for the fractionation of middle molecular substances (MMS) in plasma from conservatively treated patients, from dialysed patients with renal failure and in the ultradiafiltrate from dialysed ones. The following observations were made:
  1. 1.

    MMS accumulate in the plasma of conservatively treated patients in chronic renal failure.

     
  2. 2.

    The accumulation of MMS in dialysed patients is even higher.

     
  3. 3.

    The elimination of the most important MMS in the ultradiafiltrate is excellent.

     
  4. 4.

    It is concluded that hemofiltration and ultradiafiltration are indicated also for the removal of MMS, namely in the case of clinical complications which cause a further accumulation of MMS.

     

Keywords

Public Health Filtration Renal Failure Fractionation Chronic Renal Failure 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Adam, J., Dzúrik, R., Valovičová, E.: Ninhydrin-positive substances in serum and urine of patients with chronic uraemia.Clin. Chim. Acta, 39, 241 (1972).Google Scholar
  2. 2.
    Albaugh, E. W.: High performance liquid chromatographic data.J. Chromatog., 111, 250 (1975).Google Scholar
  3. 3.
    Babb, A. L., Popovich, R. P., Christopher, T. G., Scribner, B. H.: The genesis of square meter-hour hypothesis.Trans. Amer. Soc. Artif. Int. Org., 17, 81 (1971).Google Scholar
  4. 4.
    Bergström, J., Fürst, P.: Uremic middle molecules.Clin. Nephrol., 5, 143 (1976).PubMedGoogle Scholar
  5. 5.
    Bergström, J., Asaba, H., Fürst, P., Gordon, A., Quadracci, L., Zimmerman, L.: Middle molecules in uremia. Proc. 6th Int. Congr. Nephrol., Florence 1972, p. 600.Google Scholar
  6. 6.
    Božek, P., Daněková, H., Dzúrik, R., Řezníček, J.: Obsah strednemolekulových látok v sére pacientov s renálnou insuficienciou zaradených v hemodialyzačnom programe.Biochem. Clin. Bohemoslov., 4, 17 (1975).Google Scholar
  7. 7.
    Božek, P., Dzúrik, R., Daněková, H., Řezníček, J., Zvara, V.: Obsah strednomolekulových látok v sére pacientov po transplantácii obličiek.Čas. Lék. čes., 116, 52 (1977).Google Scholar
  8. 8.
    Brown, P. R.: High pressure liquid chromatography. Academic Press, New York-London 1970.Google Scholar
  9. 9.
    Dzúrik, R., Božek, P., Řezníček, J., Oborniková, A.: Blood level of middle molecular substances during uremia and hemodialysis.Proc. EDTA, 10, 263 (1973).Google Scholar
  10. 10.
    Ekman, R.: Gel chromatography on sephadex gels with narrow particle size. Distribution obtained by dry gel elutriation.Anal. Biochem., 70, 123 (1976).Google Scholar
  11. 11.
    Fürst, P., Zimmerman, L., Bergström, J.: Determination of endogenous middle molecules in normal and uremic body fluids.Clin. Nephrol., 5, 178 (1976).Google Scholar
  12. 12.
    Gróf, J., Menyhárt, J.: Comparison of serum fractions of MMS prepared by different methods. 1. Donausymposium für Nephrologie 1976. Verlag Carl Bindernagel, Friedberg/Hessen 1977.Google Scholar
  13. 13.
    Hanicki, Z., Sarnecka-Keller, M., Klein, A., Slizowska, K.: Middle-sized ninhydrinpositive molecules in uraemic patients treated by repeated haemodialysis. I. Preliminary characteristics.Clin. Chim. Acta, 54, 47 (1974).PubMedGoogle Scholar
  14. 14.
    Migone, L., Dall'Aglio, P., Buzio, C.: Middle molecules in uremic serum, urine and dialysis fluid.Clin. Nephrol., 3, 82 (1975).PubMedGoogle Scholar
  15. 15.
    Peters, J. H., Gotch, F. A., Keen, M., Berridge, B. J. Jr., Chao, W. R.: Investigation of the clearance and generation rate of endogenous peptides in normal subjects and uremic patients.Trans. Amer. Soc. Artif. Int. Org., 20, 417 (1974).Google Scholar

Copyright information

© Akadémiai Kiadó 1979

Authors and Affiliations

  • P. Božek
    • 1
    • 2
  • J. Erben
    • 1
    • 2
  • J. Zahradnik
    • 1
    • 2
  • R. Dzúrik
    • 1
    • 2
  1. 1.Research Laboratory of Experimental TherapyInstitute of Human Nutrition, 3rd Medical ClinicBratislava
  2. 2.1st Medical ClinicDialysing CenterHradec KrálovéCzechoslovakia

Personalised recommendations